PepStar Therapeutics
PrivateLast Round
M&A
Oct 22, 2026
Momentum
Top 1%
of companies Caplight tracks
Company Overview
PepStar Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in March 2026.
PepStar Therapeutics is a biotechnology company that develops novel peptide-based medicines for the treatment of oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PepStar Therapeutics Comparables
Compare PepStar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avere Therapeutics | 85% |
For institutional investors. Book with your work email.
PepStar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 22, 2026 | ||||
| Series A | Mar 1, 2026 | ||||
| Angel | Sep 24, 2024 | ||||
| Seed | Sep 1, 2023 |
For institutional investors. Book with your work email.
PepStar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Capital | Angel |
| LongRiver Investments | Seed, Angel, Series A |
| Lilly Asia Ventures | Seed |
| Hankang Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$1.3B round with Gilead Sciences
- Mar 1, 2026
Raised Series A with Hankang Capital and LongRiver Investments.
For institutional investors. Book with your work email.
PepStar Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PepStar Therapeutics's valuation, stock price, and market status.
Is PepStar Therapeutics a public or private company?
PepStar Therapeutics is a private company.
What is the current stock price of PepStar Therapeutics?
PepStar Therapeutics is a private company, so its shares have no public market price. Caplight tracks PepStar Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PepStar Therapeutics worth (valuation)?
Valuation information for PepStar Therapeutics is not publicly available.
Can I buy PepStar Therapeutics stock?
PepStar Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PepStar Therapeutics's last funding round?
PepStar Therapeutics's most recent funding round was M&A on October 22, 2026.
Who are the main investors in PepStar Therapeutics?
Key investors in PepStar Therapeutics include Legend Capital, LongRiver Investments, Lilly Asia Ventures, Hankang Capital.
Will PepStar Therapeutics IPO soon?
No public IPO plans have been announced for PepStar Therapeutics.
How can I track PepStar Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PepStar Therapeutics's shares on secondary markets.